Inhibitor Therapeutics, Inc. (INTI)

CIK 1042418 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inhibitor Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 17, 2026DEF 14A0001493152-26-038636
Aug 14, 202610-Q0001493152-26-038288
Aug 4, 202640001493152-26-035950
Aug 4, 202640001493152-26-035962
Aug 4, 202640001493152-26-036080
Aug 4, 202640001493152-26-035955
Aug 4, 202640001493152-26-035953
Jun 24, 202640001493152-26-029898
Jun 1, 202640001493152-26-026623
May 15, 202610-Q0001493152-26-023622
Apr 1, 20268-K0001493152-26-014517
Apr 1, 20268-K0001493152-26-014637
Mar 26, 202610-K0001493152-26-012751
Feb 24, 20268-K0001493152-26-007821
Nov 13, 202510-Q0001493152-25-022178
Oct 27, 20258-K0001493152-25-019381
Aug 13, 202510-Q0001641172-25-023465
May 14, 202510-Q0001641172-25-010110
Apr 10, 202540001641172-25-003556
Apr 7, 202540001641172-25-003029
Apr 7, 202540001641172-25-003033
Apr 7, 202540001641172-25-003025
Apr 7, 202540001641172-25-003023
Mar 28, 202510-K0001641172-25-001190
Feb 19, 202550001493152-25-007628